RxDoctor Payments Data

Andrea Esparza

Primary Care · Montgomery, ALNPI 1174138929

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 31.8% of the total. Reporting peaked in 2021 at $1,744 and has fallen 96.7% since, to $57 in 2023.

$3,191in general payments, 2019–2025

Across 207 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$604
  • Gilead$333
  • Pfizer$218
  • Evoke Pharma, Inc.$183
  • Intra-sana Laboratories$152
  • plus $686 from 13 others

What the payments were for

  • Food & beverage$3,09197%
  • Gifts$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,191 in reported general payments places this provider in the 80th percentile of 159 primary care providers in Alabama.

See all primary care providers in Alabama

Other primary care in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →